Time of Metastatic Disease Presentation and Volume of Disease are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

BACKGROUND: Currently, there is no universally accepted prognostic classification for patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC) treated with androgen deprivation therapy (ADT). Subgroup analyses demonstrated that pts with low volume (LV), per CHAARTED trial definition,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Prostate
Main Authors: Francini, Edoardo, Gray, Kathryn P., Xie, Wanling, Shaw, Grace K., Valença, Loana, Bernard, Brandon, Albiges, Laurence, Harshman, Lauren C., Kantoff, Philip W., Taplin, Mary-Ellen, Sweeney, Cristopher J.
Format: Artigo
Sprog:Inglês
Udgivet: 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171350/
https://ncbi.nlm.nih.gov/pubmed/29707790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23645
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker